ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,343Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 1278

$531K Total Retail Price of All Prescriptions

Rank: 107 out of 1278

486 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,030 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 338 254 1 1
LEVOTHYROXINE SODIUM 317 216 2 2
METOPROLOL TARTRATE 258 196 3 9
OMEPRAZOLE 256 173 4 6
SIMVASTATIN 253 199 5 3
HYDROCODONE-ACETAMINOPHEN 248 169 S3 6 7
FUROSEMIDE 184 145 7 10
METFORMIN HCL 180 113 8 4
HYDROCHLOROTHIAZIDE 174 146 9 8
AMLODIPINE BESYLATE 153 103 10 5
WARFARIN SODIUM 149 81 11 17
OXYCODONE-ACETAMINOPHEN 148 70 S2 12 29
GABAPENTIN 143 107 13 12
CITALOPRAM HBR 117 71 14 22
POTASSIUM CHLORIDE 109 66 15 21
TRAMADOL HCL 107 74 16 25
ATENOLOL 107 83 16 11
TRAZODONE HCL 103 66 18 38
ALBUTEROL SULFATE 103 35 18 169
FENTANYL 102 40 S2 20 97
RANITIDINE HCL 93 45 21 20
OXYCODONE HCL 92 39 S2 22 27
FLUTICASONE PROPIONATE 92 42 22 24
IPRATROPIUM-ALBUTEROL 83 63 24 176
SERTRALINE HCL 81 65 25 28
METOPROLOL SUCCINATE 79 72 26 23
ZOLPIDEM TARTRATE 78 50 27 16
POLYETHYLENE GLYCOL 3350 77 16 28 105
DONEPEZIL HCL 68 66 29 48
PANTOPRAZOLE SODIUM 67 52 30 34
PRAVASTATIN SODIUM 67 62 30 14
PAROXETINE HCL 66 49 32 56
ALLOPURINOL 65 54 33 36
LIDODERM 64 47 34 165
CARVEDILOL 63 46 35 39
LANTUS 63 41 35 33
PROAIR HFA 59 35 37 26
QUETIAPINE FUMARATE 57 43 38 126
HYDRALAZINE HCL 56 21 39 108
BACLOFEN 51 0 40 113
KLOR-CON M20 50 33 41 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.